Programmed cell death ligand 1 (PD-L1) plays an important role in mediating immune response and in tumour tolerance1 by binding to programmed cell death-1 (PD-1) on T lymphocytes and promoting T-cell exhaustion, apoptosis, and selective suppression of tumour-specific T-cells2. This evidence concerns the gene CD274 and neoplasm.